Cargando…
Cyclodextrin-based nanosponges as drug carriers
Cyclodextrin-based nanosponges, which are proposed as a new nanosized delivery system, are innovative cross-linked cyclodextrin polymers nanostructured within a three-dimensional network. This type of cyclodextrin polymer can form porous insoluble nanoparticles with a crystalline or amorphous struct...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Beilstein-Institut
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520565/ https://www.ncbi.nlm.nih.gov/pubmed/23243470 http://dx.doi.org/10.3762/bjoc.8.235 |
_version_ | 1782252798611554304 |
---|---|
author | Trotta, Francesco Zanetti, Marco Cavalli, Roberta |
author_facet | Trotta, Francesco Zanetti, Marco Cavalli, Roberta |
author_sort | Trotta, Francesco |
collection | PubMed |
description | Cyclodextrin-based nanosponges, which are proposed as a new nanosized delivery system, are innovative cross-linked cyclodextrin polymers nanostructured within a three-dimensional network. This type of cyclodextrin polymer can form porous insoluble nanoparticles with a crystalline or amorphous structure and spherical shape or swelling properties. The polarity and dimension of the polymer mesh can be easily tuned by varying the type of cross-linker and degree of cross-linking. Nanosponge functionalisation for site-specific targeting can be achieved by conjugating various ligands on their surface. They are a safe and biodegradable material with negligible toxicity on cell cultures and are well-tolerated after injection in mice. Cyclodextrin-based nanosponges can form complexes with different types of lipophilic or hydrophilic molecules. The release of the entrapped molecules can be varied by modifying the structure to achieve prolonged release kinetics or a faster release. The nanosponges could be used to improve the aqueous solubility of poorly water-soluble molecules, protect degradable substances, obtain sustained delivery systems or design innovative drug carriers for nanomedicine. |
format | Online Article Text |
id | pubmed-3520565 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Beilstein-Institut |
record_format | MEDLINE/PubMed |
spelling | pubmed-35205652012-12-14 Cyclodextrin-based nanosponges as drug carriers Trotta, Francesco Zanetti, Marco Cavalli, Roberta Beilstein J Org Chem Review Cyclodextrin-based nanosponges, which are proposed as a new nanosized delivery system, are innovative cross-linked cyclodextrin polymers nanostructured within a three-dimensional network. This type of cyclodextrin polymer can form porous insoluble nanoparticles with a crystalline or amorphous structure and spherical shape or swelling properties. The polarity and dimension of the polymer mesh can be easily tuned by varying the type of cross-linker and degree of cross-linking. Nanosponge functionalisation for site-specific targeting can be achieved by conjugating various ligands on their surface. They are a safe and biodegradable material with negligible toxicity on cell cultures and are well-tolerated after injection in mice. Cyclodextrin-based nanosponges can form complexes with different types of lipophilic or hydrophilic molecules. The release of the entrapped molecules can be varied by modifying the structure to achieve prolonged release kinetics or a faster release. The nanosponges could be used to improve the aqueous solubility of poorly water-soluble molecules, protect degradable substances, obtain sustained delivery systems or design innovative drug carriers for nanomedicine. Beilstein-Institut 2012-11-29 /pmc/articles/PMC3520565/ /pubmed/23243470 http://dx.doi.org/10.3762/bjoc.8.235 Text en Copyright © 2012, Trotta et al. https://creativecommons.org/licenses/by/2.0https://www.beilstein-journals.org/bjoc/termsThis is an Open Access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The license is subject to the Beilstein Journal of Organic Chemistry terms and conditions: (https://www.beilstein-journals.org/bjoc/terms) |
spellingShingle | Review Trotta, Francesco Zanetti, Marco Cavalli, Roberta Cyclodextrin-based nanosponges as drug carriers |
title | Cyclodextrin-based nanosponges as drug carriers |
title_full | Cyclodextrin-based nanosponges as drug carriers |
title_fullStr | Cyclodextrin-based nanosponges as drug carriers |
title_full_unstemmed | Cyclodextrin-based nanosponges as drug carriers |
title_short | Cyclodextrin-based nanosponges as drug carriers |
title_sort | cyclodextrin-based nanosponges as drug carriers |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520565/ https://www.ncbi.nlm.nih.gov/pubmed/23243470 http://dx.doi.org/10.3762/bjoc.8.235 |
work_keys_str_mv | AT trottafrancesco cyclodextrinbasednanospongesasdrugcarriers AT zanettimarco cyclodextrinbasednanospongesasdrugcarriers AT cavalliroberta cyclodextrinbasednanospongesasdrugcarriers |